102 related articles for article (PubMed ID: 1666351)
1. Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alpha.
Yefenof E; Algarra I; Ramos OF; Klein E
Complement Inflamm; 1991; 8(5-6):271-80. PubMed ID: 1666351
[TBL] [Abstract][Full Text] [Related]
2. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
Kurakata S; Ramos OF; Klein G; Klein E
Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
[TBL] [Abstract][Full Text] [Related]
4. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma.
Klein G; Yefenof E; Falk K; Westman A
Int J Cancer; 1978 May; 21(5):552-60. PubMed ID: 207646
[TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
McConnell I; Klein G; Lint TF; Lachmann PJ
Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
[TBL] [Abstract][Full Text] [Related]
8. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma.
Klein G; Hyman R; Trowbridge I
Int J Cancer; 1979 Jan; 23(1):37-41. PubMed ID: 215562
[TBL] [Abstract][Full Text] [Related]
9. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers.
Torsteinsdottir S; Masucci MG; Lenoir G; Klein G; Klein E
Cell Immunol; 1984 Jul; 86(2):278-86. PubMed ID: 6329520
[TBL] [Abstract][Full Text] [Related]
11. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
[TBL] [Abstract][Full Text] [Related]
12. [Cytokine-regulating activity of anti-virus preparation CelAgripus in Burkitt's lymphoma stable B-cell lines.].
Narovlyansky AN; Mezentseva MV; Suetina IA; Russu LI; Ivanova AM; Poloskov VV; Izmest'eva AV; Ospelnikova TP; Sarymsakov AA; Ershov FI
Vopr Virusol; 2019; 64(4):165-172. PubMed ID: 32163682
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement system.
Marquart HV; Olesen EH; Johnson AA; Damgaard G; Leslie RG
Scand J Immunol; 1997 Sep; 46(3):246-53. PubMed ID: 9315112
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus regulates activation and processing of the third component of complement.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
[TBL] [Abstract][Full Text] [Related]
16. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
[TBL] [Abstract][Full Text] [Related]
17. IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Jun; 142(11):3862-7. PubMed ID: 2523936
[TBL] [Abstract][Full Text] [Related]
18. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.
Olesen EH; Johnson AA; Damgaard G; Leslie RG
Immunology; 1998 Feb; 93(2):177-83. PubMed ID: 9616366
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
20. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
